HCV and IDUs: A legacy for the millennium

International Journal of Drug Policy

Volumn 9, Issue 1, 1998, Pages 63-69

  Wells, Paul ^a  

^a Coventry Community Drug Team ^*  (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0007015576     PISSN: 09553959     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0955-3959(97)00008-X     Document Type: Article

References (31)

1. Advisory Council on the Misuse of Drugs, AIDS and DRUG MISUSE Update, 1993.
2. Advisory Council on the Misuse of Drugs, Drug Misusers and the Prison System, 1996.
3. Carruthers S. Determining which injecting practices are risky: Filming users using, presentation to the First Australasian Conference on Hepatitis C, Sydney, 1997.
4. Centre for Research on Drugs and Health Behaviour, Hepatitis C Among Injecting Drug Users; Executive Summary Number 50, June 1996.
5. Crofts N. Hepatitis C Virus: The Other Epidemic, Todays Life Science (Sept).
6. Crofts N, et al. Spread of blood borne viruses among Australian prison entrants. Br Med J 1995:310.
7. Crofts N, et al. Hepatitis C in a cohort of Victorian injecting drug users, presentation to the First Australasian Conference on Hepatitis C, Sydney, 1997a.
8. Crofts N, Jolley D, Kaldor J, et al. The epidemiology of hepatitis C virus infection among injecting drug users in Australia. J Epidemiol Community Health 1997b.
9. Department of Health. Preventing the Spread of HIV Infection Among and From Injecting Drug Misusers, 1988.
10. Department of Health. Additional Sites for HIV Antibody Testing (PL/CO(92)5, 1992.
11. Department of Health. Purchasing Effective Treatment and Care for Drug Misusers.
12. Department of Health. Statistical Bulletin: Drug Misuse Statistics (No 7), 1997.
13. Dolan K. Hepatitis C in prisons, presentation to the First Australasian Conference on Hepatitis C, Sydney, 1997.
14. Dore G, et al. The role of Polymerase Chain Reaction (PCR) in defining level of infectivity among people with Hepatitis C Virus (HCV) infection: A review, presentation to the First Australasian Conference on Hepatitis C, Sydney, 1997.
15. Duscheiko G, et al. A rational approach to the management of Hepatitis C infection. Br Med J 1996:312.
16. Flynn N, et al. Seeing is believing: Videotaped highrisk injection behaviour, presentation to the 7th International Conference on the Reduction of Drug Related Harm, Hobart, 1996.
17. Garfein R, et al. Viral infections in short-term injection drug users: the prevalence of the hepatitis C, B human immunodeficiency and human T-lymphotropic viruses, Am J Pub Health 1996:86.
18. Khan M, et al. Adverse clinical outcomes in patients with chronic Hepatitis C: Lack of affect of alcohol intake, and apparent beneficial effect of Interferon treatment, presentation to the First Australasian Conference on Hepatitis C, Sydney, 1997.
19. Langkham B. High HCV prevalence among injecting drug users in northeast India, presentation to the First Australasian Conference on Hepatitis C, Sydney, 1997.
20. Lenton S, Sharing reusing and Hepatitis C in a sample of 'hidden' drug injectors, presentation to the First Australasian Conference on Hepatitis C, Sydney, 1997.
21. MacDonald M, et al. Hepatitis C antibody among IDU at Australian needle exchanges, presentation to the First Australasian Conference on Hepatitis C, Sydney, 1997.
22. MacDonald M, et al. Transmission of Hepatitis C virus: Rates, routes and cofactors, Epidemiol Rev 1997.
23. National Health and Medical Research Council. Strategy for the detection and management of Hepatitis C in Australia, 1996.
24. Sladden T, et al. Hepatitis C transmission on the north coast of New South Wales: explaining the unexplained, Med J Am 1997:166.
25. Task Force to Review Services for Drug Misusers, Department of Health, 1996.
26. Waller T, Holmes R. Time to Wake Up, Druglink, May/June, 1993.
27. Waller T, Holmes R. Hepatitis C: Scale and impact in Britain-the sleeping giant awakes, Druglink, September/October, 1995.
28. Wells P. Hepatitis C (HCV): The failure to provide a strategic response, presentation to the 7th International Conference on the Reduction of Drug Related Harm, Hobart, 1996.
29. West Midlands NHS Executive unpublished report into injecting and sexual risk behaviour, 1997.
30. Wodak A, Crofts N. Once more into the breach: Controlling hepatitis C in injecting drug users, Addiction 1996:91.
31. Wodak A. Hepatitis C: Waiting for the grim reaper. Med J Am 1997:166.